Replicel Life Sciences Stock Shares Owned By Institutions
| REPCF Stock | USD 0 0.00 0.00% |
RepliCel Life Sciences fundamentals help investors to digest information that contributes to RepliCel Life's financial success or failures. It also enables traders to predict the movement of RepliCel Pink Sheet. The fundamental analysis module provides a way to measure RepliCel Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RepliCel Life pink sheet.
RepliCel |
RepliCel Life Sciences Company Shares Owned By Institutions Analysis
RepliCel Life's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
| Competition |
Based on the latest financial disclosure, 0.0% of RepliCel Life Sciences are shares owned by institutions. This is 100.0% lower than that of the Life Sciences Tools & Services sector and 100.0% lower than that of the Health Care industry. The shares owned by institutions for all United States stocks is 100.0% higher than that of the company.
RepliCel Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RepliCel Life's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of RepliCel Life could also be used in its relative valuation, which is a method of valuing RepliCel Life by comparing valuation metrics of similar companies.RepliCel Life is currently under evaluation in shares owned by institutions category among its peers.
RepliCel Fundamentals
| Return On Asset | -1.65 | |||
| Operating Margin | (4.19) % | |||
| Current Valuation | 3.42 M | |||
| Shares Outstanding | 54.36 M | |||
| Shares Owned By Insiders | 68.42 % | |||
| Price To Earning | (1.00) X | |||
| Price To Sales | 8.35 X | |||
| Revenue | 353.74 K | |||
| Gross Profit | 353.74 K | |||
| EBITDA | (4.07 M) | |||
| Net Income | (4.07 M) | |||
| Cash And Equivalents | 228 K | |||
| Total Debt | 34.26 K | |||
| Current Ratio | 0.23 X | |||
| Book Value Per Share | (0.22) X | |||
| Cash Flow From Operations | (2.51 M) | |||
| Earnings Per Share | (0.09) X | |||
| Number Of Employees | 23 | |||
| Beta | 1.19 | |||
| Market Capitalization | 5.29 M | |||
| Total Asset | 591.79 K | |||
| Retained Earnings | (14.76 M) | |||
| Z Score | 39.0 | |||
| Net Asset | 591.79 K |
About RepliCel Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RepliCel Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RepliCel Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RepliCel Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in RepliCel Pink Sheet
RepliCel Life financial ratios help investors to determine whether RepliCel Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RepliCel with respect to the benefits of owning RepliCel Life security.